20 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
Communications with the Board of Directors
Policy Prohibiting Hedging or Pledging of Securities
Code of Business Conduct and Ethics
Environmental, Social … Code of Business Conduct and Ethics;
adopts and oversees procedures to address complaints regarding accounting, internal accounting controls
DFAN14A
EX-99.1
Kayne Richard A
4 May 22
Additional proxy materials by non-management
10:56am
, regulatory affairs, drug safety, and medical ethics. Dr. Krall oversaw a budget of over $1.5 billion as part of his drug development and regulatory
DFAN14A
EX-99.1
l909ik4nlv6f 1gkf3xx
25 Apr 22
Additional proxy materials by non-management
3:31pm
DFAN14A
EX-99.6
ct16oi4
22 Apr 22
Additional proxy materials by non-management
10:07am
DEFC14A
d7y9k bge4f195
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
h19qf
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
DEF 14A
cvvrteyjnq20 rt3vmr
16 Apr 21
Definitive proxy
6:02am
10-K
2rk0 wegzax
25 Mar 21
Annual report
12:00am
424B4
2nz616qhnkvyb gk
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
9dq6h5
6 Jan 21
Draft registration statement
12:00am
424B4
wa4 eu4mq1a4dh
18 Sep 20
Prospectus supplement with pricing info
4:05pm
S-1
qaygb
26 Aug 20
IPO registration
5:25pm
DRS
50yadeexeum qe3
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next